You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 22, 2024

CLINICAL TRIALS PROFILE FOR SOTRADECOL


✉ Email this page to a colleague

« Back to Dashboard


All Clinical Trials for SOTRADECOL

Trial ID Title Status Sponsor Phase Start Date Summary
NCT00442364 ↗ Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt Completed Boston Scientific Corporation Phase 2 2007-03-01 The purpose of this study is to determine the safety of the Varisolve® procedure in patients with right-to-left cardiac shunt (a defect in the heart).
NCT00442364 ↗ Safety Study of Varisolve® Procedure for Treatment of Varicose Veins in Patients With Right-to-left Cardiac Shunt Completed BTG International Inc. Phase 2 2007-03-01 The purpose of this study is to determine the safety of the Varisolve® procedure in patients with right-to-left cardiac shunt (a defect in the heart).
NCT01408732 ↗ Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Completed American Rhinologic Society Phase 1/Phase 2 2011-02-01 The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
NCT01408732 ↗ Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Completed University of Minnesota Phase 1/Phase 2 2011-02-01 The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
NCT01408732 ↗ Office-sclerotherapy for Epistaxis Due to Hereditary Hemorrhagic Telangiectasia Completed University of Minnesota - Clinical and Translational Science Institute Phase 1/Phase 2 2011-02-01 The purpose of this study is to test a novel and tolerable office-based treatment method, sclerotherapy with sodium tetradecyl sulfate, for recurrent epistaxis (nosebleeds) related to Hereditary Hemorrhagic Telangiectasia (HHT) disease.
>Trial ID >Title >Status >Phase >Start Date >Summary

Clinical Trial Conditions for SOTRADECOL

Condition Name

Condition Name for SOTRADECOL
Intervention Trials
Epistaxis 1
Hereditary Hemorrhagic Telangiectasia 1
Varicose Veins 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Condition MeSH

Condition MeSH for SOTRADECOL
Intervention Trials
Epistaxis 1
Varicose Veins 1
Telangiectasis 1
Telangiectasia, Hereditary Hemorrhagic 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Locations for SOTRADECOL

Trials by Country

Trials by Country for SOTRADECOL
Location Trials
United States 6
This preview shows a limited data set
Subscribe for full access, or try a Trial

Trials by US State

Trials by US State for SOTRADECOL
Location Trials
Minnesota 1
Washington 1
Texas 1
Pennsylvania 1
North Carolina 1
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Progress for SOTRADECOL

Clinical Trial Phase

Clinical Trial Phase for SOTRADECOL
Clinical Trial Phase Trials
Phase 2 1
Phase 1/Phase 2 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Status

Clinical Trial Status for SOTRADECOL
Clinical Trial Phase Trials
Completed 2
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Clinical Trial Sponsors for SOTRADECOL

Sponsor Name

Sponsor Name for SOTRADECOL
Sponsor Trials
Boston Scientific Corporation 1
BTG International Inc. 1
American Rhinologic Society 1
[disabled in preview] 2
This preview shows a limited data set
Subscribe for full access, or try a Trial

Sponsor Type

Sponsor Type for SOTRADECOL
Sponsor Trials
Other 4
Industry 1
[disabled in preview] 0
This preview shows a limited data set
Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.